{"url_path":"/sec/numd/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1543637/0001575872-26-000326-index.html","accession_number":"0001575872-26-000326","cik":"0001543637","ticker":"NUMD","issuer_name":"Nu-Med Plus, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1543637/0001575872-26-000326-index.html","primary_entity_key":"0001543637","primary_entity_name":"Nu-Med Plus, Inc."},"word_count":62,"has_tables":true,"body_markdown":"ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds\n\n \n\nRecent Sales of Unregistered Securities\n\n \n\nNone.\n\n \n\nOther Securities Transactions\n\n \n\nNone.\n\n \n\nUse of Proceeds of Registered Securities\n\n \n\nNone.\n\n \n\nPurchases of Equity Securities by Us and Affiliated Purchasers\n\n \n\nDuring the three months ended March 31, 2026, we have not purchased any equity securities nor have any officers or directors of the Company.\n\n \n\n17"}